Data / Form D filings / Renovare Therapeutics, Inc.
Renovare Therapeutics, Inc.: Form D filing
Renovare Therapeutics, Inc., a biotechnology company in Boulder, CO, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $100,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8871 TAHOE COURT, Boulder, CO, 80301
- Phone
- (919) 381-7314
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2158361
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Sep 14 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elizabeth A Scott | Executive Officer, Director | |
| Stephanie Bryant | Director | |
| Karin Payne | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8
Every Form D from the week of Sep 28 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Renovare Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.